Browsing by Author Russ, Graeme

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 17 of 17
Issue DateTitleAuthor(s)Citation
2017Association between delayed graft function and graft loss in donation after cardiac death kidney transplants-A paired kidney registry analysisChapman, Jeremy; Pleass, Henry; Wong, Germaine; Jaques, B; Lim, Wai H; Ma, Maggie; McDonald, Stephen P; Russ, Graeme; Westmead Clinical School: Medicine; Westmead Clinical School: Surgery; School of Public Health: Public HealthAssociation between delayed graft function and graft loss in donation after cardiac death kidney transplants-A paired kidney registry analysis, Transplantation, vol.101, 6, 2017,pp 1139-1143
2005Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation.Chapman, Jeremy; Brault, Yves; BURKE, JAMES T; Campistol, Josep M.; Grinyo, Josep M.; Hartmann, Anders; Kreis, Henri; Lawen, Joseph; MOTA, ALFREDO; Neylan, John F.; OBERBAUER, RAINER; Pinto, Jose R.; Russ, Graeme; Segoloni, Giuseppe; Stallone, Giovanni; Western Clinical School: Westmead Millennium InstituteEarly cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation., Transplant International, vol.18,(1),2005,pp 22-28
2010Effect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipientsChadban, Steven; Campbell, Scott; Dent, Hannah; Lim, Wai H.; McDonald, Stephen P.; Russ, Graeme; Central Clinical School: MedicineEffect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipients, Transplant International, vol.23, 12,pp 1207-1215
2003Geographic variance in access to renal transplantation in AustraliaChapman, Jeremy; Russ, Graeme; Western Clinical School: Westmead Millennium InstituteGeographic variance in access to renal transplantation in Australia, Transplantation, vol.76,(9),2003,pp 1403-1406
2012Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipientsChadban, Steven; Budgeon, Charley A; Campbell, Scott; Clayton, Philip; Cohney, Solomon; Lim, Wai H.; McDonald, Stephen P; Murray, Kevin; Russ, Graeme; Central Clinical School: MedicineHuman leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients, Clinical Transplantation, vol.26, 4, 2012,pp E428-E437
2007Kidney Transplant Rejection in Australia and New Zealand: Relationships between rejection and graft outcomeChadban, Steven; Campbell, Scott; McDonald, Stephen; Russ, Graeme; Central Clinical School: MedicineKidney Transplant Rejection in Australia and New Zealand: Relationships between rejection and graft outcome, American Journal Of Transplantation, vol.7,(5),2007,pp 1201-1208
2016Maternal compared with paternal donor kidneys are associated with poorer graft outcomes after kidney transplantationChapman, Jeremy; Wong, Germaine; Coates, P Toby; Lim, Wai H; McDonald, Stephen; Russ, Graeme; Western Clinical School: Westmead Institute for Medical Res; School of Public Health: Public HealthMaternal compared with paternal donor kidneys are associated with poorer graft outcomes after kidney transplantation, Kidney International, vol.89, 3, 2016,pp 659-665
2016Maternal compared with paternal donor kidneys are associated with poorer graft outcomes after kidney transplantationChapman, Jeremy; Wong, Germaine; Coates, P Toby; Lim, Wai H; McDonald, Stephen; Russ, Graeme; Western Clinical School: Westmead Institute for Medical Res; School of Public Health: Public HealthMaternal compared with paternal donor kidneys are associated with poorer graft outcomes after kidney transplantation, Kidney International, vol.89, 3, 2016,pp 659-665
2016Mortality among Younger and Older Recipients of Kidney Transplants from Expanded Criteria Donors Compared with Standard Criteria DonorsChapman, Jeremy; Craig, Jonathan; Wong, Germaine; Lim, Wai H; Ma, Maggie; Russ, Graeme; Western Clinical School: Westmead Institute for Medical Res; School of Public Health: Public Health; School of Public Health: Public HealthMortality among Younger and Older Recipients of Kidney Transplants from Expanded Criteria Donors Compared with Standard Criteria Donors, Clinical Journal of the American Society of Nephrology, vol.11, 1, 2016,pp 128-136
2006A one-year, randomised, open label, parallel group study to investigate the safety and efficacy of enteric-coated Mycophenolate sodium (EC-MPS) in combination with full dose or reduced dose cyclosporine microemulsion (CSA-ME), basiliximab and steroids in de novo kidney transplantationChadban, Steven; Chapman, Jeremy; Ierino, Francesco; Walker, Raellen; Campbell, Sandra J; Hutchison, Brian; Irish, A.; Pussell, Bruce A.; Russ, Graeme; Thompson, N.; Trevillian, P; Central Clinical School: Medicine; Western Clinical School: Westmead Millennium Institute; Medicine Faculty Office; School of Public Health: NH&MRC Clinical Trials CentreA one-year, randomised, open label, parallel group study to investigate the safety and efficacy of enteric-coated Mycophenolate sodium (EC-MPS) in combination with full dose or reduced dose cyclosporine microemulsion (CSA-ME), basiliximab and steroids in de novo kidney transplantation, Immunology and Cell Biology, vol.84,(3),2006,pp A6-A6
2013A randomized, controlled trial of everolimus based dual immunosuppression vs standard of care in de novo kidney transplant recipientsChadban, Steven; Eris, Josette; Kanellis, John; Kurstjens, Nicol Peter; Lee, Po Chang; Lim, Soo Kun; Pilmore, Helen L.; Russ, Graeme; Woodcock, Chad; Central Clinical School: Medicine; Concord Clinical School: MedicineA randomized, controlled trial of everolimus based dual immunosuppression vs standard of care in de novo kidney transplant recipients, Transplant International, vol.27, 3, 2013,pp 302-311
2014A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipientsChadban, Steven; Eris, Josette; Kanellis, John; Kurstjens, Nicol Peter; Lee, Po Chang; Lim, Soo Kun; Pilmore, Helen L.; Russ, Graeme; Woodcock, Chad; Central Clinical School: Medicine; Concord Clinical School: MedicineA randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients, Transplant International, vol.27, 3, 2014,pp 302-311
2011A review of utility-based allocation strategies to maximize graft years of deceased donor kidneysChadban, Steven; Campbell, Scott; Cohney, Solomon; Lim, Wai H.; McDonald, Stephen; Russ, Graeme; Central Clinical School: MedicineA review of utility-based allocation strategies to maximize graft years of deceased donor kidneys, Nephrology, vol.16, 4, 2011,pp 368-376
2017The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporineChadban, Steven; Wong, Germaine; Kanellis, John; Lim, Wai H; Pilmore, Helen L.; Russ, Graeme; Central Clinical School: Medicine; School of Public Health: Public HealthThe risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine, Kidney International, vol.91, 4, 2017,pp 954-963
2006Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.Eris, Josette; Campistol, Josep M.; Claesson, Kerstin; et, al; Friend, Peter; Hutchison, Brian; Morales, Jose M.; Oberbauer, Rainer; Rostaing, Lionel; Russ, Graeme; Stallone, Giovanni; Concord Clinical School: MedicineSirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation., Journal of the American Society of Nephrology, vol.17,(2),2006,pp 581-589
2006Sirolimus therapy after early cyclosporine withdrawal reduces the risk of malignancy at 5 years after renal transplantationChapman, Jeremy; Eris, Josette; Walker, Raellen; Brault, Yves; Burke, James; Campbell, Scott; Hutchison, Brian; Mahoney, John; Neylan, John F.; Pussell, Bruce A.; Russ, Graeme; Scarola, Joseph; Western Clinical School: Westmead Millennium Institute; Concord Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreSirolimus therapy after early cyclosporine withdrawal reduces the risk of malignancy at 5 years after renal transplantation, Immunology and Cell Biology, vol.84,(3),2006,pp A19-A19
2007Trends in Kidney Transplantation in Australia and New Zealand, 1993-2004Chadban, Steven; Campbell, Scott; Chang, Sean; McDonald, Stephen; Russ, Graeme; Central Clinical School: MedicineTrends in Kidney Transplantation in Australia and New Zealand, 1993-2004, Transplantation 2005, vol.84,(5),2007,pp 611-618